Howland Capital Management’s Boston Scientific BSX Stock Holding History

Howland Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,475	Closed	-$236K	–	265
2025 Q4	$236K	Hold	2,475	–	–	0.01%	252
2025 Q3	$242K	Sell	2,475 -36	-1%	-$3.73K	0.01%	257
2025 Q2	$270K	Sell	2,511 -19	-0.8%	-$1.92K	0.01%	246
2025 Q1	$255K	Sell	2,530 -316	-11%	-$31.8K	0.01%	246
2024 Q4	$254K	Buy	2,846 +6	+0.2%	+$528	0.01%	268
2024 Q3	$238K	Hold	2,840	–	–	0.01%	262
2024 Q2	$219K	Buy	+2,840	New	+$208K	0.01%	260

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Howland Capital Management's BSX Position: Q1 2026 in Review

Howland Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,475 shares — an estimated $236K sold.

Howland Capital Management first reported a position in BSX in Q2 2024 and held it in 7 quarters. The position peaked at $270K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Howland Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Howland Capital Management sold 2,475 Boston Scientific shares in Q1 2026, an estimated $236K.
Howland Capital Management first reported a position in Boston Scientific in Q2 2024 and held it in 7 quarters.
Howland Capital Management's Boston Scientific position peaked at $270K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Howland Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.